Mastering the U.S. Regulatory Landscape
Bridged Clinical provides the clarity and strategic foresight required to navigate complex FDA pathways. We partner with international life sciences, medical device, and diagnostics companies to ensure successful submissions and rapid U.S. market entry.
Our Strategic Process
A structured, outcome-focused methodology designed to accelerate U.S. market entry while ensuring total regulatory compliance and clarifying complex FDA requirements.
01
Assessment
Gap analysis of existing clinical data against FDA standards to determine shortcut potential and regulatory hurdles.
02
Strategy
Crafting a U.S.-specific regulatory roadmap, including classification, predicate device identification, and Pre-Sub meetings.
03
Execution
Operational startup of clinical trials through our U.S. site network and evidence collection aligned with FDA expectations.
04
Submission
Final dossier preparation and management of all FDA correspondence to secure timely 510(k), De Novo, or PMA clearance.
Accelerated Market Entry. Minimized Regulatory Risk.
Faster Startup: Leverage our established U.S. clinical site network for immediate enrollment.
Regulatory Clarity: Clear, actionable roadmaps tailored to current FDA expectations for medical devices or diagnostics.
Successful Submissions: Expert guidance on clinical evidence and technical documentation to ensure a smooth approval process.
Case Studies & Success Stories
Driving efficient market entry with technical clarity and reliable regulatory execution for global leaders.
Diagnostic Manufacturer — East Asia
Rapid FDA 510(k) Clearance for Molecular NAT Device
Navigated complex pre-submission queries to secure 510(k) clearance in record time, enabling immediate U.S. commercial activity. The strategy focused on addressing data gaps before formal submission.
14-Month Approval
Medical Device Startup — Europe
FDA De Novo Submission & Clinical Trial Execution
Managed multi-site clinical trials across 12 U.S. centers. Successfully established a new device classification while maintaining rigorous quality standards and accelerated enrollment timelines.
Faster Startup: -40% Timeline